Domestic pharmaceutical-biopharmaceutical companies concludes technology exports of USD 600 million in half year
Domestic pharmaceutical and biopharmaceutical companies’ results in R&D have been drawn out. Just like the last year, they showed results in global technology exports this year.
According to HI Investment & Securities on the 21st, the amount of domestic pharmaceutical and biopharmaceutical compa...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
